Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × Pafolacianine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Sarcoma 1 Pituitary Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1

Interventions

Doxorubicin 24 Cyclophosphamide 24 Gemcitabine 14 Radiotherapy 12 Filgrastim 11 pazopanib 10 pembrolizumab 9 Cisplatin 9 Docetaxel 8 Radiation 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Carboplatin 7 Busulfan 7 fludarabine 6 Trabectedin 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Melphalan 6 Ipilimumab 6 Etoposide 6 Bevacizumab 6 selinexor 5 olaratumab 5 Temozolomide 5 Leucovorin 5 Irinotecan 5 aflibercept 4 Topotecan 4 Thiotepa 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06235125 2024-08-22

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡